The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Monday Deal Review: June 1, 2009

B&W_BigNickelLooks like most people were too busy at ASCO to make new deals, but there was a bit of Canadian activity this week. Read on

Oncothyreon Closes:  Oncothyreon Inc. (NASDAQ: ONTY, TSX: ONY) closed the registered offering that they announced last week.  You can read the prospectus here.

MedMira and the Magic Porridge Pot its Equity Line of Credit: MedMira Inc., (NASDAQ: MMIRF, TSX-V: MIR) closed its latest Equity Line draw-down for net proceeds of $142,500 – the draw down amount ($150,000) less a 5% utilization fee.   They enjoyed it so much, they’re doing it again for another $150,000.

And that is it for now, folks.

Bookmark and Share

About these ads

One response to “Monday Deal Review: June 1, 2009

  1. Pingback: Monday Deal Review: June 22, 2009 « The Cross-Border Biotech Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 126 other followers